Capital Fund Management S.A. Bristol Myers Squibb CO Put Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $55.3 Million - $72.1 Million	-1,393,800 Reduced 34.84%	2,606,400 $135 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $63 Million - $82.9 Million	1,565,100 Added 64.27%	4,000,200 $166 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $26.9 Million - $30.5 Million	-560,100 Reduced 18.7%	2,435,100 $132 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $57.3 Million - $68.4 Million	1,181,900 Added 65.18%	2,995,200 $154 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $59.6 Million - $66.7 Million	1,030,000 Added 131.49%	1,813,300 $105 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $21 Million - $23.3 Million	329,600 Added 72.65%	783,300 $50.1 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $13.7 Million - $15.5 Million	-207,800 Reduced 31.41%	453,700 $31.4 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $5.36 Million - $6.35 Million	78,300 Added 13.43%	661,500 $47.6 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $28,587 - $16.9 Million	219,900 Added 60.53%	583,200 $41.5 Billion
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $6.75 Million - $7.44 Million	93,000 Added 34.41%	363,300 $28 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $5.45 Million - $6.53 Million	88,600 Added 48.76%	270,300 $19.7 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $4.14 Million - $4.83 Million	77,200 Added 73.88%	181,700 $11.3 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $2.46 Million - $2.88 Million	41,500 Added 65.87%	104,500 $6.18 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $2.18 Million - $2.46 Million	-36,800 Reduced 36.87%	63,000 $3.98 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $19.1 Million - $21.7 Million	-331,100 Reduced 76.84%	99,800 $6.19 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $1.61 Million - $1.79 Million	28,100 Added 6.98%	430,900 $26 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $33 Million - $38.6 Million	-602,400 Reduced 59.93%	402,800 $23.7 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $8.25 Million - $12 Million	177,700 Added 21.47%	1,005,200 $56 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $22.5 Million - $29.3 Million	456,900 Added 123.29%	827,500 $53.1 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $1.69 Million - $2.01 Million	39,600 Added 11.96%	370,600 $18.8 Million
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $771,926 - $853,582	-17,300 Reduced 4.97%	331,000 $15 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $12 Million - $14.4 Million	-267,000 Reduced 43.39%	348,300 $16.6 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $11.4 Million - $14.8 Million	-234,700 Reduced 27.61%	615,300 $32 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $40.3 Million - $45.5 Million	-731,100 Reduced 46.24%	850,000 $52.8 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $76.4 Million - $95.3 Million	1,512,600 Added 2208.18%	1,581,100 $87.5 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $2.2 Million - $2.53 Million	-36,700 Reduced 34.89%	68,500 $4.33 Million
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $1.98 Million - $2.16 Million	-33,100 Reduced 23.93%	105,200 $6.45 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $7.64 Million - $8.82 Million	138,300	138,300 $8.82 Million

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.15 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.36 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.49 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.52 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account